evertex fabrinology limited reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 110.46 million compared to TWD 148.2 million a year ago. Revenue was TWD 149.46 million compared to TWD 209.31 million a year ago. Net income was TWD 8.54 million compared to net loss of TWD 6.06 million a year ago. Basic earnings per share from continuing operations was TWD 0.1 compared to basic loss per share from continuing operations of TWD 0.07 a year ago. Diluted earnings per share from continuing operations was TWD 0.1 compared to diluted loss per share from continuing operations of TWD 0.07 a year ago.
For the six months, sales was TWD 299.81 million compared to TWD 382.6 million a year ago. Revenue was TWD 381.47 million compared to TWD 509.23 million a year ago. Net income was TWD 43.82 million compared to TWD 20.83 million a year ago. Basic earnings per share from continuing operations was TWD 0.51 compared to TWD 0.24 a year ago. Diluted earnings per share from continuing operations was TWD 0.51 compared to TWD 0.24 a year ago.